Credit: Shutterstock
Liver transplant recipients are more susceptible to cancer, especially skin cancers, new Flinders University research shows.
Of the 198 people who had a liver transplant or were managed post-transplant in South Australia between 1991 and 2010, a quarter of patients developed post-transplant malignancies, with skin cancer being the most common (16 per cent) and the remaining nine per cent being solid organ malignancies, including lymphoma, lung, prostate and colorectal cancer.
The study, undertaken by Flinders Professor Bogda Koczwara, SA Liver Transplant Unit Director Dr John Chen and Perth oncologist Hilary Martin, aimed to assess overall survival rates for patients with post-transplant malignancies.
The recipients were aged between 19 and 64 years, with the majority of patients being treated for liver failure due to cirrhosis.
Dr Chen, based at Flinders Medical Centre, said the reason liver transplant recipients incurred a greater risk of cancer was because of the side-effects of immunosuppressive drugs, which prevent the patient's body from rejecting the organ.
"When you perform a transplant you have to lower the patient's immunity so they don't reject the organ but there's a price to pay, and that price is an increased risk of infections and malignancies," Dr Chen said.
"Transplant rejection used to be a major problem in the past but we've significantly improved the process of immunosuppression – the only problem is the side-effects remain an issue," he said.
"While there's been a lot of work done to fine-tune these drugs to minimise the risk of infection and malignancies, we still need to work out the right combination for different patients."
The study showed recipients diagnosed with a skin cancer that could be treated locally had an excellent prognosis, with none of the patients developing disease progression, recurrence or dying from the skin malignancies.
Patients with solid tumours had substantially worse overall survival, at 47 per cent compared with the skin cancer group of 88 per cent during the follow-up period.
Of the patients with solid tumours, those suitable for local therapy alone had satisfactory outcomes, however those with advanced malignancies requiring systemic therapy experienced significant treatment-related toxicities and had poor outcomes.
Dr Chen said because transplants were so successful these days, recipients were living longer and therefore had an even greater vulnerability to cancer, which often occurs later in life.
Until scientists find a way to minimise the adverse effects of immunosuppression, he said transplant recipients required ongoing surveillance and monitoring.
"The main thing we can do is regular check-ups for skin cancers, and for patients who are at high risk of other cancers, such as smokers, we can survey the aerodigestive tract and for older patients we can do periodic colonic surveillance to look for large bowel tumours.
"Although it's more common for liver transplant recipients to develop cancer, the good news is they can be cured with early detection and treatment."
The study was published earlier this month in the Asia-Pacific Journal of Clinical Oncology.
Explore further: Renal risk index: A clinical tool to predict the risk of end-stage renal disease
Medical Xpress on facebook
Related Stories
Renal risk index: A clinical tool to predict the risk of end-stage renal disease
Oct 01, 2013
End-stage renal disease is one of the major public health problems among solid organ transplant recipients that is associated with death after transplant and high cost of care.
Recipients of organ transplants at increased risk for broad range of cancers
Nov 01, 2011
Patients who have received a solid organ transplant, such as kidney, liver, heart or lung, have an overall cancer risk that is double that of the general population, with an increased risk for many different types of malignancies, ...
Alcoholism treatment before, after liver transplantation reduces relapse
Oct 03, 2013
New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation. ...
Exercise may reduce heart disease risk in liver transplant recipients
Aug 06, 2013
New research reveals that metabolic syndrome—risk factors that can lead to heart disease and/or stroke—is common in liver transplant recipients, with rates highest at one year following the procedure. Findings published ...
Cancerous cells from donor kidney linked to recipient skin cancer
Aug 27, 2013
Patients that receive kidney transplants have an increased risk of an invasive form of skin cancer. It is unclear if donor tissue contributes to cancer formation.
Recommended for you
Scientists find novel way to 'switch on' tumour suppressors that have been silenced
1 hour ago
A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) and their collaborators from the Harvard Stem Cell Institute have found that a novel noncoding ...
Cancer drug nexavar tied to pancreas damage in two patients
14 hours ago
(HealthDay)—The cancer drug sorafenib, known by its trade name Nexavar, could have a toxic effect on the pancreas of patients who take it for extended periods.
Standard, RHDVRT for bladder cancer has comparable tumor control, decreased toxicity
15 hours ago
Standard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide comparable tumor control and decreased late toxicity when compared to surgery, according to a study published in the October ...
New technique allows anti-breast cancer drugs to cross blood-brain barrier
16 hours ago
Some breast cancer drugs can penetrate the blood-brain barrier (BBB), but they have not been very effective against brain metastases, whereas other, more effective anti-breast cancer drugs cannot penetrate the BBB at all. ...
Does good cholesterol increase breast cancer risk?
19 hours ago
High levels of high density lipoprotein (HDL), also known as the "good cholesterol," are thought to protect against heart disease. However, what's good for one disease may not be good for another. High levels of HDL have ...
Multivitamins with minerals may protect older women with invasive breast cancer
21 hours ago
Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals. The new research, published ...
User comments
© Medical Xpress 2011-2013, Phys.org network
Credit: Shutterstock
Liver transplant recipients are more susceptible to cancer, especially skin cancers, new Flinders University research shows.
Of the 198 people who had a liver transplant or were managed post-transplant in South Australia between 1991 and 2010, a quarter of patients developed post-transplant malignancies, with skin cancer being the most common (16 per cent) and the remaining nine per cent being solid organ malignancies, including lymphoma, lung, prostate and colorectal cancer.
The study, undertaken by Flinders Professor Bogda Koczwara, SA Liver Transplant Unit Director Dr John Chen and Perth oncologist Hilary Martin, aimed to assess overall survival rates for patients with post-transplant malignancies.
The recipients were aged between 19 and 64 years, with the majority of patients being treated for liver failure due to cirrhosis.
Dr Chen, based at Flinders Medical Centre, said the reason liver transplant recipients incurred a greater risk of cancer was because of the side-effects of immunosuppressive drugs, which prevent the patient's body from rejecting the organ.
"When you perform a transplant you have to lower the patient's immunity so they don't reject the organ but there's a price to pay, and that price is an increased risk of infections and malignancies," Dr Chen said.
"Transplant rejection used to be a major problem in the past but we've significantly improved the process of immunosuppression – the only problem is the side-effects remain an issue," he said.
"While there's been a lot of work done to fine-tune these drugs to minimise the risk of infection and malignancies, we still need to work out the right combination for different patients."
The study showed recipients diagnosed with a skin cancer that could be treated locally had an excellent prognosis, with none of the patients developing disease progression, recurrence or dying from the skin malignancies.
Patients with solid tumours had substantially worse overall survival, at 47 per cent compared with the skin cancer group of 88 per cent during the follow-up period.
Of the patients with solid tumours, those suitable for local therapy alone had satisfactory outcomes, however those with advanced malignancies requiring systemic therapy experienced significant treatment-related toxicities and had poor outcomes.
Dr Chen said because transplants were so successful these days, recipients were living longer and therefore had an even greater vulnerability to cancer, which often occurs later in life.
Until scientists find a way to minimise the adverse effects of immunosuppression, he said transplant recipients required ongoing surveillance and monitoring.
"The main thing we can do is regular check-ups for skin cancers, and for patients who are at high risk of other cancers, such as smokers, we can survey the aerodigestive tract and for older patients we can do periodic colonic surveillance to look for large bowel tumours.
"Although it's more common for liver transplant recipients to develop cancer, the good news is they can be cured with early detection and treatment."
The study was published earlier this month in the Asia-Pacific Journal of Clinical Oncology.
Explore further: Renal risk index: A clinical tool to predict the risk of end-stage renal disease
Medical Xpress on facebook
Related Stories
Renal risk index: A clinical tool to predict the risk of end-stage renal disease
Oct 01, 2013
End-stage renal disease is one of the major public health problems among solid organ transplant recipients that is associated with death after transplant and high cost of care.
Recipients of organ transplants at increased risk for broad range of cancers
Nov 01, 2011
Patients who have received a solid organ transplant, such as kidney, liver, heart or lung, have an overall cancer risk that is double that of the general population, with an increased risk for many different types of malignancies, ...
Alcoholism treatment before, after liver transplantation reduces relapse
Oct 03, 2013
New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation. ...
Exercise may reduce heart disease risk in liver transplant recipients
Aug 06, 2013
New research reveals that metabolic syndrome—risk factors that can lead to heart disease and/or stroke—is common in liver transplant recipients, with rates highest at one year following the procedure. Findings published ...
Cancerous cells from donor kidney linked to recipient skin cancer
Aug 27, 2013
Patients that receive kidney transplants have an increased risk of an invasive form of skin cancer. It is unclear if donor tissue contributes to cancer formation.
Recommended for you
Scientists find novel way to 'switch on' tumour suppressors that have been silenced
1 hour ago
A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) and their collaborators from the Harvard Stem Cell Institute have found that a novel noncoding ...
Cancer drug nexavar tied to pancreas damage in two patients
14 hours ago
(HealthDay)—The cancer drug sorafenib, known by its trade name Nexavar, could have a toxic effect on the pancreas of patients who take it for extended periods.
Standard, RHDVRT for bladder cancer has comparable tumor control, decreased toxicity
15 hours ago
Standard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide comparable tumor control and decreased late toxicity when compared to surgery, according to a study published in the October ...
New technique allows anti-breast cancer drugs to cross blood-brain barrier
16 hours ago
Some breast cancer drugs can penetrate the blood-brain barrier (BBB), but they have not been very effective against brain metastases, whereas other, more effective anti-breast cancer drugs cannot penetrate the BBB at all. ...
Does good cholesterol increase breast cancer risk?
19 hours ago
High levels of high density lipoprotein (HDL), also known as the "good cholesterol," are thought to protect against heart disease. However, what's good for one disease may not be good for another. High levels of HDL have ...
Multivitamins with minerals may protect older women with invasive breast cancer
21 hours ago
Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals. The new research, published ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment